Iowa 2025-2026 Regular Session Status: Enacted

SF 383 — A bill for an act relating to pharmacy benefits managers, pharmacies, prescription drugs, and pharmacy services administrative organizations, and including applicability provisions.

Last action — Signed by Governor.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced February 19, 2025. Enacted.

Signed by Governor Kim Reynolds (Republican) on June 11, 2025.

Prognosis

Advancing 54% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Mixed recorded votes

    2 passed, 2 failed in recorded votes so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

What changed in the latest version

334 added · 380 removed

Plain-language change summary

The updated version of Senate File 383 has added definitions for "national average drug acquisition" and "wholesale acquisition cost." These changes are important as they aim to clarify how prescription drug pricing is determined, potentially benefiting consumers by enhancing transparency around drug costs. This could lead to better understanding and management of pharmacy benefits and costs for patients.

→
Previous
Latest
S T A T E O F I O W A K I M R E Y N O L D S G O V E R N O R June11,2025 The Honorable Paul Pate SecretaryofStateofIowa StateCapitolBuilding L O C A L DearMr.Secretary, IherebytransmitSenateFile383,anactrelatingtopharmacybenefitsmanagers,pharmacies, prescriptiondrugs,andpharmacyservicesadministrativeorganizations,andincluding applicabilityprovisions.
Senate File 383 - Enrolled Senate File 383 AN ACT RELATING TO PHARMACY BENEFITS MANAGERS, PHARMACIES, PRESCRIPTION DRUGS, AND PHARMACY SERVICES ADMINISTRATIVE ORGANIZATIONS, AND INCLUDING APPLICABILITY PROVISIONS.
As Governorofthisgreatstate,Ihaveworkedtirelesslytotransformlegacysystemsoftaxation, regulation,education,healthcare,workforce,andeconomicdevelopmentinanefforttoprovide lowanswiththebestpossiblereturnontheirinvestmentandcontinuetomovethisstateforward.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
Afterextensiveresearchandthoughtfulconversationswithemployersandstakeholdersonall sidesofthiscomplexissue,ImadethedecisiontosignSF383inanefforttocontinueimproving ourhealthcaresystembybringinggreateraccountabilitytotheroleofPharmacyBenefit Managers(PBMs).Inenactingthisbillintolaw,IowajoinsTexas,Georgia,IndianaandMontana thatthisyearpassedsimilarlegislationtoaddressthisimportantissuealongwithseveralother statesthathavedonesopreviously,bringingthetotalto32states.
DIVISION I PHARMACY BENEFITS MANAGERS Section 1.
PBMs playacentralroleinthepharmaceuticalsupplychain,negotiatingdrugpricesandaccess formillionsofAmericans.Overtime,consolidationhasledtothreemajorPBMs controlling 80% ofthemarketandacloseaffiliationwithbothinsurersandpharmacies.Thisvertical integrationgivesthemoutsizedpoweroverwhich medicationspatientsreceiveandwhatthey pay—oftenresultinginunaffordabledrugcosts,difficultchoicesforfamilies,andreimbursement belowpharmacy acquisitioncost.
Section 510B.1, Code 2025, is amended by adding the following new subsections:
Thenew billtakesstepstowardaddressingthesechallengesbytargetingPBM practicesthat harmbothpatientsandindependentpharmacies.Localpharmacies,especiallyinruralareas,are vitaltocommunity healthandlocalhospitalsbutarebeingdrivenoutby opaque,one-sided contracts—evidencedbytheclosureof34ruralpharmaciesinIowalastyear.Additionally,this legislationamplifiestheruralhealthcarebillwe passedthissessionandisameaningfulstep towardafairer,moretransparent,andaccessiblehealthcaresystemforall.
NEW SUBSECTION .
STATE CAPITOL DES MOINES,IOWA 50319 515.281.5211WWW.GOVERNOR.IOWA.GOV Buthsblldoesnoinfyanend.Thecomplexityandlriibledatamadgnng tisiladffcltdecision,andmyadministrationwillcloselymonitorimplementationto mtiateandnurehtanyuinenedcoseuenesfrpivteemployereadrssd.We wllasobelaunchingareverseauctiontoenttehealthplancontinuestokeepcosts aslowaspossibleforthestsemployees.
11A.
Sincerely, Kim Reynolds GovernorofIowa cc:
“National average drug acquisition cost” means the monthly survey of retail pharmacies conducted by the federal centers for Medicare and Medicaid services to determine average acquisition cost for Medicaid covered outpatient drugs.
SecretaryoftheSenate Clerk ofthe House fi!GHT M M N T A J G E N E R A L A S S E M B I S e n aP i l3 8 3 A NA C T RELATING TO PHARMACY BENEFITS MANAGERS, PHARMACIES, P R E S C R I D R U G S , A N D P H A R M A C Y S E R V I C E S A D M I N I S T R A T I V E O R G A N I Z A T I I N C L U DA P P L I C A B I L I T Y P R O V I S I O N S , B E I T E N A C T T H E G E N A S S E M B L Y O F T H E SI O W A :O F D I V I S I O N P H A R MB E N E F M A N A G E R S Section 1, Section 510B.1, Code 2025, is amended by adding the following new subsections:
NEW SUBSECTION .
NEW SUBSECTION.
11B.
IIA.
“Pass-through pricing” means a model of prescription drug pricing in which payments made by a third-party payor to a pharmacy benefits manager for prescription drugs are equivalent to the payments the pharmacy benefits manager makes to the dispensing pharmacy or dispensing health care provider for the prescription drugs, including any professional dispensing fee.
^National average drug acquisition cost" means the monthly survey of retail pharmacies conducted by the federal centers for Medicare and Medicaid services to determine average acquisition cost for Medicaid covered outpatient drugs.
NEW SUBSECTION .
NEW SUBSECTION.
IIB.
'^Pass-through pricing" means a model of prescription drug pricing in which payments made by a third-party payor to a pharmacy benefits manager for prescription drugs are equivalent to the payments the pharmacy benefits manager makes to the dispensing pharmacy or dispensing health care provider for the prescription drugs, including any professional dispensing fee.
NEW SUBSECTION.
'^Pharmacy chain" means an entity that has twenty or more pharmacies under common ownership or control located in at least twenty or more states.
“Pharmacy chain” means an entity that has twenty or more pharmacies under common ownership or control located in at least twenty or more states.
NEW SUBSECTION.
NEW SUBSECTION .
21A, ""Retail pharmacy" means a pharmacy that is not a pharmacy chain or a publicly traded entity, and Senate File 383, p.
21A.
“Retail pharmacy” means a pharmacy that is not a pharmacy chain or a publicly traded entity, and Senate File 383, p.
NEW SUBSECTION.
NEW SUBSECTION .
21B, ^Specialty drug" means a drug used to treat chronic and complex, or rare medical conditions and that requires special handling or administration, provider care coordination, or patient education that cannot be provided by a nonspecialty pharmacy or pharmacist.
21B.
NEW SUBSECTION.
“Specialty drug” means a drug used to treat chronic and complex, or rare medical conditions and that requires special handling or administration, provider care coordination, or patient education that cannot be provided by a nonspecialty pharmacy or pharmacist.
NEW SUBSECTION .
"^Wholesale acquisition cost" means the same as defined in 42 U.S.C, §1395w-3a(c)(6)(B).
“Wholesale acquisition cost” means the same as defined in 42 U.S.C.
§1395w-3a(c)(6)(B).
NEW SUBSECTION, 4.
NEW SUBSECTION .
A pharmacy benefits manager, health carrier, health benefit plan, or third-party payor shall not discriminate against a pharmacy or a pharmacist with respect to participation, referral, reimbursement of a covered service, or indemnification if a pharmacist is acting within the scope of the pharmacist's license, as permitted under state law, and the pharmacy is operating in compliance with all applicable laws a n r u l e s .
4.
A pharmacy benefits manager, health carrier, health benefit plan, or third-party payor shall not discriminate against a pharmacy or a pharmacist with respect to participation, referral, reimbursement of a covered service, or indemnification if a pharmacist is acting within the scope of the pharmacist’s license, as permitted under state law, and the pharmacy is operating in compliance with all applicable laws and rules.
510B.4B Prohibited conduct — pharmacy rights.
510B.4B Prohibited conduct —— pharmacy rights.
If a pharmacy or pharmacist has agreed to participate in a covered person's health benefit plan, prohibit or limit the covered person from selecting a pharmacy or pharmacist of the covered person's choice, or impose a monetary advantage or penalty that would affect a covered person's choice.
If a pharmacy or pharmacist has agreed to participate in a covered person’s health benefit plan, prohibit or limit the covered person from selecting a pharmacy or pharmacist of the covered person’s choice, or impose a monetary advantage or penalty that would affect a covered person’s choice.
3 pharmacies• c.
3 pharmacies.
c.
Unreasonably designate a prescription drug as a specialty drug to prevent a covered person from accessing the prescription drug, or limiting a covered person's access to the prescription drug, from a pharmacy or pharmacist that is within the health carrier's network, A covered person or pharmacy harmed by an alleged violation of this paragraph may file a complaint with the commissioner, and the commissioner shall, in consultation with the board of pharmacy, make a determination as to whether the covered prescription drug meets the definition of a specialty drug.
Unreasonably designate a prescription drug as a specialty drug to prevent a covered person from accessing the prescription drug, or limiting a covered person’s access to the prescription drug, from a pharmacy or pharmacist that is within the health carrier’s network.
A covered person or pharmacy harmed by an alleged violation of this paragraph may file a complaint with the commissioner, and the commissioner shall, in consultation with the board of pharmacy, make a determination as to whether the covered prescription drug meets the definition of a specialty drug.
b» The third-party payor shall inform covered persons of the names and locations of all pharmacies participating in the health benefit plan as providers of pharmacy services and prescription drugs.
b.
c, A participating pharmacy shall be entitled to announce to the pharmacy's customers that the pharmacy participates in the health benefit plan.
The third-party payor shall inform covered persons of the names and locations of all pharmacies participating in the health benefit plan as providers of pharmacy services and prescription drugs.
c.
A participating pharmacy shall be entitled to announce to the pharmacy’s customers that the pharmacy participates in the health benefit plan.
A covered person or pharmacy injured by a violation of this section may maintain a cause of action to enjoin the c o n t i n u a tt h v i o l a t i o n .
A covered person or pharmacy injured by a violation of this section may maintain a cause of action to enjoin the continuation of the violation.
NEW SUBSECTION.
NEW SUBSECTION .
Show all 91 changed rows (51 more)
Previous
Latest
NEW SUBSECTION.
NEW SUBSECTION .
NEW SUBSECTION.
NEW SUBSECTION .
5, A pharmacy benefits manager shall include any amount paid by a covered person, or on behalf of a covered person, when calculating the covered person's total contribution toward the covered person's cost-sharing.
5.
NEW SUBSECTION.
A pharmacy benefits manager shall include any amount paid by a covered person, or on behalf of a covered person, when calculating the covered person’s total contribution toward the covered person’s cost-sharing.
NEW SUBSECTION .
Any amount paid by a covered person for a prescription drug shall be applied to any deductible imposed on the covered person by the covered person's health benefit plan in accordance with the health benefit plan's coverage d o c u m e n t s .
Any amount paid by a covered person for a prescription drug shall be applied to any deductible imposed on the covered person by the covered person’s health benefit plan in accordance with the health benefit plan’s coverage documents.
NEW SUBSECTION.
NEW SUBSECTION .
If a covered person's policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses qualifies as a high-deductible health plan under section 223 of the Internal Revenue Code, Senate File 383, p.
If a covered person’s policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses qualifies as a high-deductible health plan under section 223 of the Internal Revenue Code, Senate File 383, p.
5 and a copayment, coinsurance, or deductible paid by the covered person as a cost-sharing requirement under this chapter would result in the covered person becoming ineligible for a health savings account associated with the covered person's high-deductible health plan, subsection 5 shall apply only after the covered person satisfies the covered person's minimum deductible, except for items or services determined to be preventive care under section 223(c)(2)(C) of the Internal R e v e C o d e .
5 and a copayment, coinsurance, or deductible paid by the covered person as a cost-sharing requirement under this chapter would result in the covered person becoming ineligible for a health savings account associated with the covered person’s high-deductible health plan, subsection 5 shall apply only after the covered person satisfies the covered person’s minimum deductible, except for items or services determined to be preventive care under section 223(c)(2)(C) of the Internal Revenue Code.
Section 510B.8B, Code 2025, is amended to read as f o l l o w s :
Section 510B.8B, Code 2025, is amended to read as follows:
510B.8B Pharmacy benefits manager affiliates managers — roimburaemGnt reimbursements.
510B.8B Pharmacy benefits manager affiliates managers —— reimbursement reimbursements.
The reimburaemont amount shall be calculated on a per unit basis based on the same generic product identifier or generic code number.
The reimbursement amount shall be calculated on a per unit basis based on the same generic product identifier or generic code number.
a, A pharmacy benefits manager shall submit a quarterly report to the commissioner of all drugs reimbursed at ten percent or more below the national average drug acquisition Senate File 383, p.
a.
A pharmacy benefits manager shall submit a quarterly report to the commissioner of all drugs reimbursed at ten percent or more below the national average drug acquisition Senate File 383, p.
For each prescription drug included in the report, a pharmacy benefits manager shall include all of the following i n f o r m a t i o n ;
For each prescription drug included in the report, a pharmacy benefits manager shall include all of the following information:
( 3 )The amount the pharmacy was reimbursed.
(3) The amount the pharmacy was reimbursed.
(4) If the dispensing pharmacy was an affiliate of the pharmacy benefits manager, (5) If the prescription drug was dispensed pursuant to a government health plan.
(4) If the dispensing pharmacy was an affiliate of the pharmacy benefits manager.
(5) If the prescription drug was dispensed pursuant to a government health plan.
A copy of the report shall be published on the pharmacy benefits manager^s public internet site for twenty-four months after the date the report is submitted to the commission.
A copy of the report shall be published on the pharmacy benefits manager’s public internet site for twenty-four months after the date the report is submitted to the commission.
510B.8D Pharmacy benefits manager c o n t r a c t s .
510B.8D Pharmacy benefits manager contracts.
All contracts executed, amended, adjusted, or renewed on or after July 1, 2025, that apply to prescription drug benefits on or after January 1, 2026, between a pharmacy benefits manager and a third-party payor, or between a person and a third-party payor, shall include all of the following requirements! a.
All contracts executed, amended, adjusted, or renewed on or after July 1, 2025, that apply to prescription drug benefits on or after January 1, 2026, between a pharmacy benefits manager and a third-party payor, or between a person and a third-party payor, shall include all of the following requirements:
a.
Payments received by a pharmacy benefits manager for services provided by the pharmacy benefits manager to a third-party payor or to a pharmacy shall be used or distributed pursuant to the pharmacy benefits manager's contract with the third-party payor or with the pharmacy, or as otherwise required by law.
Payments received by a pharmacy benefits manager for services provided by the pharmacy benefits manager to a third-party payor or to a pharmacy shall be used or distributed pursuant to the pharmacy benefits manager’s contract with the third-party payor or with the pharmacy, or as otherwise required by law.
a, A dedicated telephone number at which a pharmacy may contact the pharmacy benefits manager and speak directly with an individual who is involved with the appeals process.
a.
b, A dedicated electronic mail address or internet site for the purpose of submitting an appeal directly to the pharmacy benefits manager.
A dedicated telephone number at which a pharmacy may contact the pharmacy benefits manager and speak directly with an individual who is involved with the appeals process.
c, A period of no less than thirty business days after the date of a pharmacy's initial submission of a clean claim during which the pharmacy may initiate an appeal.
b.
A dedicated electronic mail address or internet site for the purpose of submitting an appeal directly to the pharmacy benefits manager.
c.
A period of no less than thirty business days after the date of a pharmacy’s initial submission of a clean claim during which the pharmacy may initiate an appeal.
If the pharmacy benefits manager grants a pharmacy's appeal related to a reimbursement rate, the pharmacy benefits manager shall do all of the following:
If the pharmacy benefits manager grants a pharmacy’s appeal related to a reimbursement rate, the pharmacy benefits manager shall do all of the following:
(b) Each pharmacy in the state that demonstrates the inability to purchase the prescription drug for less than the e s t a b l ir e i m b u r r a t e .
(b) Each pharmacy in the state that demonstrates the inability to purchase the prescription drug for less than the established reimbursement rate.
t b.
b.
If the pharmacy benefits manager denies a pharmacy's Senate File 383, p.
If the pharmacy benefits manager denies a pharmacy’s Senate File 383, p.
(2) If the prescription drug identified by the national drug code number provided by the pharmacy benefits manager pursuant to subparagraph ( 1 ) is not available below the pharmacy acquisition cost from the wholesale distributor from whom the pharmacy purchases the majority of its prescription drugs for resale, the pharmacy benefits manager shall adjust the reimbursement rate above the appealing pharmacy's pharmacy acquisition cost, and reverse and resubmit each claim affected by the pharmacy's inability to procure the prescription drug at a cost that is equal to or less than the previously appealed r e i m b u r sr a t e .t Sec.
(2) If the prescription drug identified by the national drug code number provided by the pharmacy benefits manager pursuant to subparagraph (1) is not available below the pharmacy acquisition cost from the wholesale distributor from whom the pharmacy purchases the majority of its prescription drugs for resale, the pharmacy benefits manager shall adjust the reimbursement rate above the appealing pharmacy’s pharmacy acquisition cost, and reverse and resubmit each claim affected by the pharmacy’s inability to procure the prescription drug at a cost that is equal to or less than the previously appealed reimbursement rate.
Sec.
SEVERABILITY, The provisions of this division of this Act are severable pursuant to section 4.12.
SEVERABILITY.
The provisions of this division of this Act are severable pursuant to section 4.12.
9, APPLICABILITY, This division of this Act applies to pharmacy benefits managers, health carriers, third-party payers, and health benefit plans that manage a prescription drug benefit in the state on or after July 1, 2025.
9.
D I V I SI IO N P H A R M S E R V I C E S A D M I N I S T R A T I V E W H O L E S A L E I O N S A N D D I S T R I BO FP R E S C R I D R U G S S e c .
APPLICABILITY.
1 P H A R M S E R V I C E S A D M I N I S T R A T I V E O R G A N I Z A T I O N S A N D W H O L E S A L E D I S O F P R E S C R ID R U G SR E P O R T , 1, By January 1, 2026, the commissioner of insurance, or the commissioner of insurance's designee, shall review pharmacy services administrative organizations and the wholesale distribution of prescription drugs, and submit a report to the general assembly containing the commissioner's findings and recommendations.
This division of this Act applies to pharmacy benefits managers, health carriers, third-party payors, and health benefit plans that manage a prescription drug benefit in the state on or after July 1, 2025.
DIVISION II PHARMACY SERVICES ADMINISTRATIVE ORGANIZATIONS AND WHOLESALE DISTRIBUTION OF PRESCRIPTION DRUGS Sec.
10.
PHARMACY SERVICES ADMINISTRATIVE ORGANIZATIONS AND WHOLESALE DISTRIBUTION OF PRESCRIPTION DRUGS —— REPORT.
1.
By January 1, 2026, the commissioner of insurance, or the commissioner of insurance’s designee, shall review pharmacy services administrative organizations and the wholesale distribution of prescription drugs, and submit a report to the general assembly containing the commissioner’s findings and recommendations.
A description and analysis of the prescription drug wholesale distribution supply chain, including the market concentration for the wholesale distribution of prescription drugs, margins in the wholesale distribution of prescription Senate Pile 383, p.
A description and analysis of the prescription drug wholesale distribution supply chain, including the market concentration for the wholesale distribution of prescription drugs, margins in the wholesale distribution of prescription Senate File 383, p.
Information provided by the commissioner under this section that may reveal the identity of a specific pharmacy services administrative organization or prescription drug wholesaler, or the price charged to a specific pharmacy for a specific prescription drug, shall be considered a confidential r e c o r d .
Information provided by the commissioner under this section that may reveal the identity of a specific pharmacy services administrative organization or prescription drug wholesaler, or the price charged to a specific pharmacy for a specific prescription drug, shall be considered a confidential record.
Jyyiuj AMY SINCL^^R PAT GRASSLEY.
______________________________ ______________________________ AMY SINCLAIR PAT GRASSLEY President of the Senate Speaker of the House I hereby certify that this bill originated in the Senate and is known as Senate File 383, Ninety-first General Assembly.
President of the Senate Speaker of The House I hereby certify that this bill originated in the Senate and is known as Senate File 383, Ninety-first General Assembly.
______________________________ W.
W .C H A R S M I T H S O N Secr£tj^y of Approved1 , 2025 ll * ^.
CHARLES SMITHSON Secretary of the Senate Approved _______________, 2025 ______________________________ KIM REYNOLDS Governor
K l t t ^ E ^ O L D S G o v e r n o r
⬇ Download PDF
View plain text versions (6)

Amendments

5 amendments

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. Signed by Governor.

  2. Fiscal note.

  3. Explanation of vote.

  4. Reported correctly enrolled, signed by President and Speaker, and sent to Governor.

  5. Message from House.

  6. Immediate message.

  7. Passed House, yeas 75, nays 15.

  8. Motion to suspend rules failed.

  9. Motion to suspend rules for immediate consideration of amendment H-1324, yeas 21, nays 69.

  10. Point of order raised on amendment H-1324, ruled not germane.

  11. Amendment H-1324 filed.

  12. Amendment H-1302 filed, withdrawn.

  13. Substituted for HF 852.

  14. Fiscal note.

  15. Fiscal note.

  16. Read first time, passed on file.

  17. Message from Senate.

  18. Immediate message.

  19. Passed Senate, yeas 36, nays 14.

  20. Amendment S-3104 out of order.

  21. Amendment S-3138 adopted.

  22. Amendment S-3139 filed, lost.

  23. Amendment S-3138 filed.

  24. Deferred.

  25. Amendment S-3104 filed.

  26. Fiscal note.

  27. Placed on calendar under unfinished business.

  28. Committee report, approving bill.

  29. Introduced, placed on calendar.

Sponsors

  • COMMITTEE ON HEALTH AND HUMAN SERVICES · Primary

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 149 not signed on · 115 voted No

Sponsors (1)

  • COMMITTEE ON HEALTH AND HUMAN SERVICES

Co-sponsors (0)

None.

Not signed on (149)

149 members have not signed on to this bill.

Show all 149 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Shall the bill pass?

Passed 75 Yea · 15 Nay · 9 Other
Party YeaNayPresentNot Voting
Democrat 23405
Unaffiliated 2103
Republican 511104
Total 7616012
% of votes cast 73%15%0%12%
How each member voted (104)
Member Party Vote
Jr. — Yea
Sexton — Yea
Kniff — Nay
Open — Not Voting
Rule 76 — Not Voting
invoked, 1: — Not Voting
Adam Zabner Democrat Yea
Aime Wichtendahl Democrat Not Voting
Amy Nielsen Democrat Nay
Austin Baeth Democrat Yea
Beth Wessel-Kroeschell Democrat Yea
Bob Kressig Democrat Yea
Brian Meyer Democrat Yea
Daniel Gosa Democrat Nay
David Jacoby Democrat Yea
Dr. Megan L. Srinivas Democrat Yea
Elinor A. Levin Democrat Yea
Elizabeth Wilson Democrat Yea
Eric J. Gjerde Democrat Yea
Heather Matson Democrat Yea
J.D. Scholten Democrat Yea
Jeff Cooling Democrat Nay
Jennifer Konfrst Democrat Yea
Jerome Amos Jr. Democrat Yea
Josh Turek Democrat Yea
Ken Croken Democrat Not Voting
Kenan Judge Democrat Yea
Larry McBurney Democrat Yea
Lindsay James Democrat Yea
Mary Lee Madison Democrat Yea
Monica Kurth Democrat Yea
Rick L. Olson Democrat Yea
Rob Johnson Democrat Not Voting
Ross Wilburn Democrat Nay
Ruth Ann Gaines Democrat Not Voting
Sean Bagniewski Democrat Yea
Timi M. Brown-Powers Democrat Yea
Tracy A. Ehlert Democrat Not Voting
Ann Meyer Republican Yea
Austin Harris Republican Yea
Barb Kniff McCulla Republican Nay
Bill Gustoff Republican Nay
Blaine C. Watkins Republican Yea
Bob Henderson Republican Yea
Bobby Kaufmann Republican Nay
Brent Siegrist Republican Not Voting
Brett Barker Republican Yea
Brian K. Lohse Republican Yea
Brooke Boden Republican Nay
Carter F. Nordman Republican Yea
Chad Behn Republican Yea
Chad Ingels Republican Yea
Charley Thomson Republican Yea
Christian A. Hermanson Republican Yea
Cindy Golding Republican Nay
Craig P. Johnson Republican Yea
Craig Steven Williams Republican Yea
Dan Gehlbach Republican Nay
David E. Young Republican Yea
David L. Blom Republican Yea
David Sieck Republican Not Voting
Dean Fisher Republican Yea
Derek Wulf Republican Not Voting
Devon Wood Republican Yea
Dr. Steven P. Bradley Republican Yea
Eddie Andrews Republican Yea
Gary M. Mohr Republican Nay
Hans C. Wilz Republican Yea
Heather Hora Republican Yea
Helena Hayes Republican Yea
Henry Stone Republican Yea
Jacob Bossman Republican Yea
Jane Bloomingdale Republican Yea
Jason Gearhart Republican Yea
Jennifer J. Smith Republican Yea
John H. Wills Republican Yea
Jon Dunwell Republican Yea
Joshua Meggers Republican Yea
Judd Lawler Republican Yea
Mark Cisneros Republican Yea
Mark I. Thompson Republican Yea
Matt W. Windschitl Republican Yea
Matthew Rinker Republican Yea
Megan Jones Republican Yea
Michael R. Bergan Republican Yea
Mike Vondran Republican Yea
Norlin G. Mommsen Republican Yea
Pat Grassley Republican Yea
Ray Sorensen Republican Yea
Ryan Weldon Republican Nay
Sam Wengryn Republican Yea
Samantha Fett Republican Yea
Shannon Latham Republican Yea
Shannon Lundgren Republican Yea
Skyler Wheeler Republican Nay
Steven C. Holt Republican Yea
Taylor R. Collins Republican Nay
Thomas Gerhold Republican Yea
Thomas Jay Moore Republican Yea
Thomas M. Jeneary Republican Yea
Tom Determann Republican Yea
Tom Shipley Republican Nay
Travis M. Sitzmann Republican Yea
Zach Dieken Republican Not Voting

Official roll call →

Shall the rules be suspended to consider amendment H-1324?

Failed 21 Yea · 69 Nay · 10 Other
Party YeaNayPresentNot Voting
Democrat 21605
Unaffiliated 1201
Republican 06204
Total 2270010
% of votes cast 22%69%0%10%
How each member voted (102)
Member Party Vote
Jr. — Yea
Kniff — Nay
Sexton — Nay
Open — Not Voting
Adam Zabner Democrat Yea
Aime Wichtendahl Democrat Not Voting
Amy Nielsen Democrat Yea
Austin Baeth Democrat Yea
Beth Wessel-Kroeschell Democrat Yea
Bob Kressig Democrat Nay
Brian Meyer Democrat Yea
Daniel Gosa Democrat Yea
David Jacoby Democrat Yea
Dr. Megan L. Srinivas Democrat Nay
Elinor A. Levin Democrat Yea
Elizabeth Wilson Democrat Yea
Eric J. Gjerde Democrat Yea
Heather Matson Democrat Yea
J.D. Scholten Democrat Yea
Jeff Cooling Democrat Yea
Jennifer Konfrst Democrat Yea
Jerome Amos Jr. Democrat Yea
Josh Turek Democrat Nay
Ken Croken Democrat Not Voting
Kenan Judge Democrat Nay
Larry McBurney Democrat Yea
Lindsay James Democrat Yea
Mary Lee Madison Democrat Nay
Monica Kurth Democrat Yea
Rick L. Olson Democrat Yea
Rob Johnson Democrat Not Voting
Ross Wilburn Democrat Yea
Ruth Ann Gaines Democrat Not Voting
Sean Bagniewski Democrat Nay
Timi M. Brown-Powers Democrat Yea
Tracy A. Ehlert Democrat Not Voting
Ann Meyer Republican Nay
Austin Harris Republican Nay
Barb Kniff McCulla Republican Nay
Bill Gustoff Republican Nay
Blaine C. Watkins Republican Nay
Bob Henderson Republican Nay
Bobby Kaufmann Republican Nay
Brent Siegrist Republican Not Voting
Brett Barker Republican Nay
Brian K. Lohse Republican Nay
Brooke Boden Republican Nay
Carter F. Nordman Republican Nay
Chad Behn Republican Nay
Chad Ingels Republican Nay
Charley Thomson Republican Nay
Christian A. Hermanson Republican Nay
Cindy Golding Republican Nay
Craig P. Johnson Republican Nay
Craig Steven Williams Republican Nay
Dan Gehlbach Republican Nay
David E. Young Republican Nay
David L. Blom Republican Nay
David Sieck Republican Not Voting
Dean Fisher Republican Nay
Derek Wulf Republican Not Voting
Devon Wood Republican Nay
Dr. Steven P. Bradley Republican Nay
Eddie Andrews Republican Nay
Gary M. Mohr Republican Nay
Hans C. Wilz Republican Nay
Heather Hora Republican Nay
Helena Hayes Republican Nay
Henry Stone Republican Nay
Jacob Bossman Republican Nay
Jane Bloomingdale Republican Nay
Jason Gearhart Republican Nay
Jennifer J. Smith Republican Nay
John H. Wills Republican Nay
Jon Dunwell Republican Nay
Joshua Meggers Republican Nay
Judd Lawler Republican Nay
Mark Cisneros Republican Nay
Mark I. Thompson Republican Nay
Matt W. Windschitl Republican Nay
Matthew Rinker Republican Nay
Megan Jones Republican Nay
Michael R. Bergan Republican Nay
Mike Vondran Republican Nay
Norlin G. Mommsen Republican Nay
Pat Grassley Republican Nay
Ray Sorensen Republican Nay
Ryan Weldon Republican Nay
Sam Wengryn Republican Nay
Samantha Fett Republican Nay
Shannon Latham Republican Nay
Shannon Lundgren Republican Nay
Skyler Wheeler Republican Nay
Steven C. Holt Republican Nay
Taylor R. Collins Republican Nay
Thomas Gerhold Republican Nay
Thomas Jay Moore Republican Nay
Thomas M. Jeneary Republican Nay
Tom Determann Republican Nay
Tom Shipley Republican Nay
Travis M. Sitzmann Republican Nay
Zach Dieken Republican Not Voting

Official roll call →

Shall the bill pass?

Passed 36 Yea · 14 Nay
Party YeaNayPresentNot Voting
Republican 29300
Unaffiliated 2000
Democrat 51100
Total 361400
% of votes cast 72%28%0%0%
How each member voted (50)
Member Party Vote
Celsi — Yea
De Witt — Yea
Art Staed Democrat Nay
Cindy Winckler Democrat Nay
Herman C. Quirmbach Democrat Nay
Izaah Knox Democrat Nay
Janet Petersen Democrat Nay
Janice Weiner Democrat Nay
Liz Bennett Democrat Nay
Matt Blake Democrat Nay
Mike Zimmer Democrat Yea
Molly Donahue Democrat Nay
Sarah Trone Garriott Democrat Yea
Sarah Trone Garriott Democrat Yea
Thomas Townsend Democrat Nay
Tony Bisignano Democrat Nay
William A. Dotzler Jr. Democrat Yea
Zach Wahls Democrat Yea
Adrian Dickey Republican Yea
Amy Sinclair Republican Yea
Annette Sweeney Republican Yea
Carrie Koelker Republican Yea
Charlie McClintock Republican Nay
Cherielynn Westrich Republican Yea
Dan Zumbach Republican Yea
Dave Sires Republican Yea
David D. Rowley Republican Yea
Dawn Driscoll Republican Yea
Dennis Guth Republican Yea
Doug Campbell Republican Yea
Jack Whitver Republican Yea
Jason Schultz Republican Yea
Jeff Reichman Republican Yea
Jeff Taylor Republican Yea
Jesse Green Republican Yea
Julian B. Garrett Republican Yea
Kara Warme Republican Yea
Ken Rozenboom Republican Yea
Kerry Gruenhagen Republican Yea
Kevin Alons Republican Yea
Lynn Evans Republican Yea
Mark Costello Republican Nay
Mark S. Lofgren Republican Yea
Mike Bousselot Republican Yea
Mike Klimesh Republican Yea
Mike Pike Republican Yea
Sandy Salmon Republican Yea
Scott Webster Republican Nay
Tim Kraayenbrink Republican Yea
Tom Shipley Republican Yea

Official roll call →

Shall amendment S-3139 to amendment S-3138 be adopted?

Failed 15 Yea · 34 Nay · 1 Other
Party YeaNayPresentNot Voting
Democrat 15001
Unaffiliated 1100
Republican 03200
Total 163301
% of votes cast 32%66%0%2%
How each member voted (50)
Member Party Vote
Celsi — Yea
De Witt — Nay
Art Staed Democrat Yea
Cindy Winckler Democrat Yea
Herman C. Quirmbach Democrat Yea
Izaah Knox Democrat Yea
Janet Petersen Democrat Yea
Janice Weiner Democrat Yea
Liz Bennett Democrat Yea
Matt Blake Democrat Yea
Mike Zimmer Democrat Yea
Molly Donahue Democrat Yea
Sarah Trone Garriott Democrat Yea
Sarah Trone Garriott Democrat Yea
Thomas Townsend Democrat Yea
Tony Bisignano Democrat Not Voting
William A. Dotzler Jr. Democrat Yea
Zach Wahls Democrat Yea
Adrian Dickey Republican Nay
Amy Sinclair Republican Nay
Annette Sweeney Republican Nay
Carrie Koelker Republican Nay
Charlie McClintock Republican Nay
Cherielynn Westrich Republican Nay
Dan Zumbach Republican Nay
Dave Sires Republican Nay
David D. Rowley Republican Nay
Dawn Driscoll Republican Nay
Dennis Guth Republican Nay
Doug Campbell Republican Nay
Jack Whitver Republican Nay
Jason Schultz Republican Nay
Jeff Reichman Republican Nay
Jeff Taylor Republican Nay
Jesse Green Republican Nay
Julian B. Garrett Republican Nay
Kara Warme Republican Nay
Ken Rozenboom Republican Nay
Kerry Gruenhagen Republican Nay
Kevin Alons Republican Nay
Lynn Evans Republican Nay
Mark Costello Republican Nay
Mark S. Lofgren Republican Nay
Mike Bousselot Republican Nay
Mike Klimesh Republican Nay
Mike Pike Republican Nay
Sandy Salmon Republican Nay
Scott Webster Republican Nay
Tim Kraayenbrink Republican Nay
Tom Shipley Republican Nay

Official roll call →

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SF 383?
SF 383 is sponsored by COMMITTEE ON HEALTH AND HUMAN SERVICES.
What is the current status of SF 383?
This bill has been enacted into law. Introduced February 19, 2025. Enacted.
Where can I track SF 383?
Track SF 383 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SF 383

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SF 383

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →